Clinical Trial Update: Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating motexafin gadolinium in combination with docetaxel for non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xcytrin (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED